{"id":54107,"date":"2023-02-21T17:03:24","date_gmt":"2023-02-21T16:03:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/"},"modified":"2023-02-21T17:03:24","modified_gmt":"2023-02-21T16:03:24","slug":"engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/","title":{"rendered":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO"},"content":{"rendered":"
\n

\nChronic disease management company renews focus on improving the lives of patients of its existing customer base<\/i>\n<\/p>\n

BOSTON–(BUSINESS WIRE)–Engooden Health<\/a>, a company redefining chronic disease management, today announced that veteran healthcare executive Tom Frosheiser has been selected to serve as chief executive officer. Frosheiser succeeds Tom Ferry, who has served as CEO since 2021 and will remain on the board of directors at Engooden.\n<\/p>\n

<\/a><\/p>\n

\nFrosheiser, who brings more than 30 years of experience in tech-enabled healthcare, chronic disease management, patient engagement, and population health, will help lead the company with a heightened focus on delivering value to current customers, developing new offerings and driving strategic growth.\n<\/p>\n

\n\u201cEngooden has been helping our customers provide valuable chronic disease management services to their patients, which has resulted in thousands of lives being positively impacted,\u201d said Engooden CEO Tom Frosheiser. \u201cI\u2019m honored to lead this incredible team as we focus on helping our customers better serve their patients and scale these services to reach even more people in need.\u201d\n<\/p>\n

\nHealth systems, federally qualified health centers, physician offices, and other providers nationwide rely on Engooden to provide scalable services to empower patients living with chronic diseases to take control of their conditions at home. Through technology-driven, personalized interventions by experienced and empathetic care navigators, Engooden connects with thousands of patients each month, addressing their barriers to care while providing chronic care management services, including education, coaching, and advocacy.\n<\/p>\n

\n\u201cThe team at Engooden has demonstrated that consistent, trust-based engagement helps patients better manage their health at home, improving their health outcomes and quality of life. Tom brings clarity, focus and a strong client-centric mindset to the role and is the right fit for Engooden at this time,\u201d said Carl Byers, board member at Engooden. \u201cHe has the ideal combination of skill and experience to lead Engooden through its next phase of development.\u201d\n<\/p>\n

\nAbout Engooden<\/b>\n<\/p>\n

\nEngooden Health is the only company to offer scalable chronic disease management services and technology for physicians, health systems, and payers to identify rising-risk and chronically ill patients and positively impact their health trajectories. Through technology-driven, personalized intervention by experienced and empathetic care navigators, Engooden connects with thousands of patients each month, addressing their barriers to care while helping its customers effectively manage population health and value-based care programs. Founded in 2016, Engooden Health is headquartered in Boston. For more information, visit https:\/\/www.engooden.com\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Caroline Curran
\n
Caroline.curran@metiscomm.com<\/a>
910-409-4126\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Chronic disease management company renews focus on improving the lives of patients of its existing customer base BOSTON–(BUSINESS WIRE)–Engooden Health, a company redefining chronic disease management, today announced that veteran healthcare executive Tom Frosheiser has been selected to serve as chief executive officer. Frosheiser succeeds Tom Ferry, who has served as CEO since 2021 and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54107","6":"format-standard","7":"category-industry"},"yoast_head":"\nEngooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Chronic disease management company renews focus on improving the lives of patients of its existing customer base BOSTON–(BUSINESS WIRE)–Engooden Health, a company redefining chronic disease management, today announced that veteran healthcare executive Tom Frosheiser has been selected to serve as chief executive officer. Frosheiser succeeds Tom Ferry, who has served as CEO since 2021 and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-21T16:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO\",\"datePublished\":\"2023-02-21T16:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230221005613\\\/en\\\/1718542\\\/21\\\/Engooden-main-logo_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/\",\"name\":\"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230221005613\\\/en\\\/1718542\\\/21\\\/Engooden-main-logo_%281%29.jpg\",\"datePublished\":\"2023-02-21T16:03:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230221005613\\\/en\\\/1718542\\\/21\\\/Engooden-main-logo_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230221005613\\\/en\\\/1718542\\\/21\\\/Engooden-main-logo_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/","og_locale":"en_US","og_type":"article","og_title":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend","og_description":"Chronic disease management company renews focus on improving the lives of patients of its existing customer base BOSTON–(BUSINESS WIRE)–Engooden Health, a company redefining chronic disease management, today announced that veteran healthcare executive Tom Frosheiser has been selected to serve as chief executive officer. Frosheiser succeeds Tom Ferry, who has served as CEO since 2021 and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-21T16:03:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO","datePublished":"2023-02-21T16:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/","url":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/","name":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg","datePublished":"2023-02-21T16:03:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230221005613\/en\/1718542\/21\/Engooden-main-logo_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54107"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54107\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}